Peanut Allergy Treatment Market
According to Intent Market Research, the Peanut Allergy Treatment Market is expected to grow from USD 2.5 Billion in 2024-e at a CAGR of 23.1% to touch USD 8.7 Billion by 2030. The Peanut Allergy Treatment Market is dominated by key players such as Aimmune Therapeutics, Regeneron Pharmaceuticals, Sanofi, Merck & Co., Inc., GlaxoSmithKline, and Mylan (now part of Viatris)